4//SEC Filing
Brennan Aoife 4
Accession 0000950170-25-092284
CIK 0001768446other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:37 PM ET
Size
26.6 KB
Accession
0000950170-25-092284
Insider Transaction Report
Form 4
Climb Bio, Inc.CLYM
Brennan Aoife
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-06-27+68,750→ 68,750 total - Exercise/Conversion
Restricted Stock Units
2025-06-27−68,750→ 206,250 total→ Common Stock (68,750 underlying) - Sale
Common Stock
2025-06-30$1.22/sh−20,618$25,154→ 48,132 total
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
- [F2]The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.20 to $1.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F5]The RSUs were granted on June 27, 2024 (the "Grant Date") and are scheduled to vest over four years, with 25% of the shares vesting on each of the first four anniversaries of the Grant Date, subject to the Reporting Person's continued service.
Documents
Issuer
Climb Bio, Inc.
CIK 0001768446
Entity typeother
Related Parties
1- filerCIK 0001714563
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:37 PM ET
- Size
- 26.6 KB